Home > News > Pharmaceutical News

Dr Reddy's launches Ibandronate Sodium tablets

Posted on Jul 03, 12:02PM | UNI

Mumbai, Jul 2: Pharma major, Dr Reddy s Laboratories today launched Ibandrobate Sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets in the US market, following the approval by the United States Food and Drug Administration (USFDA).

Dr Reddy s Ibandronate sodium tablets in 150 mg are available in cartons of 3 blister packs containing 1 tablets each and it is used in the treatment of Osteporosis.

The Boniva brand and generic had US sales of approximately USD 486 million for the most recent twelve months ending March 2012, a company release said.